Simulect 20 mg powder for solution for injection or infusion

Active Ingredient
Strength
  • Basiliximab: –
Dosage Form
Powder and Solvent for Solution for Injection or Infusion
Legal Category
C - restricted prescription
Last Updated
25/09/2026
SPC section shown.

Loading the document

Novartis Ireland Limited

Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, Ireland, Dublin